Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Ortec requests FDA permission to initiate CCS trial for diabetic ulcer therapy

Aug. 31, 1999

Yoshitomi discloses cytokine production inhibitors for treating and preventing allergic reactions

Aug. 25, 1999

FDA expands HUD designation for Ortec's Composite Cultured Skin

Aug. 25, 1999

Two new RAR antagonists emerge from retinoid research program at Bristol-Myers Squibb

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

L'Oreal compounds prevent skin aging in experimental models

Aug. 23, 1999

Zenyaku Kogyo will develop and market novel psoriasis treatment in Japan

Aug. 20, 1999

Gliatech's IDE for ADCON-L approved by FDA

Aug. 20, 1999

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Aug. 16, 1999

Welsh academic team studies inhibitors of retinoic acid metabolism for dermatology applications

Aug. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...